Abstract
The emergence and advances in highly active antiretroviral therapy (HAART) have promoted increased survival and quality of life for HIV-positive patients. However, its adverse effects include redistribution of fat and metabolic changes (lipodystrophy syndrome). These factors, added to the chronic inflammation by the virus, contribute to the formation of an atherogenic metabolic profile in…